Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS

Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS

Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are primary glomerulopathies leading to proteinuria, known as podocytopathies, which share syndromic and morphological similarities. Morphological similarity occurs in cases of FSGS in which the sclerotic lesion was not sampl...

Full description

Bibliographic Details
Main Authors: Crislaine Aparecida da Silva, Liliane Silvano Araújo, Maria Luíza Gonçalves dos Reis Monteiro, Lívia Helena de Morais Pereira, Marcos Vinícius da Silva, Lúcio Roberto Cançado Castellano, Rosana Rosa Miranda Corrêa, Marlene Antônia dos Reis, Juliana Reis Machado
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2019/1070495

Internet

http://dx.doi.org/10.1155/2019/1070495

Similar Items